Sergio Strozzi’s Post

As we look towards the next decade, one thing is clear: the future of healthcare is brimming with potential. Catalio Capital Management's latest move—a whopping $500 million fund dedicated to biomedical technology—is a testament to this! Investing in healthcare offers more than financial growth—it offers the chance to be part of a revolution that could redefine how we approach medicine and patient care. Catalio's bold step is a clear indicator of where the smart money is heading. For investors like us, this is an exciting time. The advancements we're seeing—and have yet to see—in healthcare will not only transform lives but also offer substantial growth opportunities. Stay tuned as we explore these groundbreaking developments and uncover the investment gems in the ever-evolving world of healthcare. The future is here, and it's full of promise! Check out the full article for more! https://loom.ly/LkekqBg #growthopportunities #investinginhealthcare #biotech

Attending the #HealthTech #Innovation Days HTID in Paris, and one of the hottest topics in the industry is being discussed here: can #biotech companies succeed outside Boston? "Everyone agrees that patnerships with universities are the right thing to do", says Pascal Prigent, CEO of GENFIT. "Americans are used to do it (n.a. develop biotech companies); they are more trained and they have more #success stories. We need in Europe more simplification + training of talent + more success stories". Lise ALTER, Managing Director @Health Innovation Agency highlights that the French government is investing into more attractive early access programs for biotech startups. "I'm sure over the next years we will have may success stories to share, in Europe and in France". Philippe Lopes-Fernandes, Executive VP, Chief Business Officer at Ipsen, moderating the panel, concludes that "we all need to work together towards the same goal", to ensure innovative therapies reach patients.

Thrilled to join Lord Mayor of Melbourne Sally Capp AO to officially open Jumar Bioincubator, Australia’s newest #biotech incubator. The state-of-the-art facilities, infrastructure and support offered by Jumar create a world-class hub for biotech innovation translation, research commercialisation and talent development, that will help to progress discoveries towards real-world patient treatments.   The official opening was hosted by founding partners WEHI, CSL, and the University of Melbourne, as well as initial investor Breakthrough Victoria and operator Cicada Innovations.   “By nurturing the next wave of biotech entrepreneurs, Jumar Bioincubator is helping to take the most exciting ideas out of research laboratories and into the world, for the benefit of our communities,” says Professor Alan Cowman AC, Acting Director, WEHI. “We need to accelerate the translation of innovative Australian discoveries into the new treatments, diagnostics and devices that can have the greatest impact on global human health – and Jumar is a vital step forward for this.” From mini brains to lab-on-a-chip wearables, the first 16 innovative early-stage ventures that have taken up residency at Jumar are working on a range of health issues across pharmaceuticals, diagnostics, medical devices, bioinformatics and health-related AI. Anne-Laure Puaux Seth Jones #Innovation #BiotechInnovation #AustralianBiotech #ResearchTranslation #BiotechStartups  

At Diversa, our core is innovation. By integrating our cutting-edge nanoparticle technology into your projects, you're not just overcoming current challenges; you're unlocking new doors for research and product development. ✨ Why Partner with Diversa? Access state-of-the-art drug delivery systems that can transform your R&D outcomes. With financial support from Activa Startups, propel your research leading to novel investigation lines or breakthrough products. 💡 Opportunity Awaits: Whether it’s enhancing drug efficacy or exploring new therapeutic areas, our tech is your gateway. Researchers looking to pioneer in their field, let’s make groundbreaking work feasible and funded. Let’s discuss how our partnership can revolutionize your R&D endeavors. ▶ This initiative is currently accepting applications from the Canary Islands, with additional regions scheduled to open for submission over the course of the year, so let's start planning! #biotechnology #nanocarriers #innovation #funding

Today, I attended #ValenciaDigitalSummit2023 with Prof. Sergi Morais, a magnificent international #tech event to foster connections between #Startups, Corporates, and #Investors.  I would like to highlight the exciting information provided by Fermín Cerezo, Innovation Director of the Valencia City Council, about the promising measures for boosting the Tech and #innovation ecosystem in our city. Also, emphasize the inspiring pitch of Evolving Therapeutics, on using bacteriophages for #earlydiagnosis and effective #therapy, aiming for precision and #personalizedmedicine. 

We're proud to be a #mediapartner of the LSX World Congress — Connecting #Innovation with #Capital. The #event takes place from 29–30 April in London, with 2000+ attendees joining. The 10th LSX World Congress gathers the founders and CEOs of innovative #biotech, #medtech and #healthtech #startups through to healthcare giants, and everyone in between. They attend alongside the sector’s most active #investors, #pharma, medtech and healthtech BD&L teams and R&D leaders. #LSXWorld brings together the people who are developing technologies, solutions and new business models to tackle the biggest healthcare challenges in the industry today, and helps answer the question; what’s next and how do we get there? Find out more 👉 https://lnkd.in/ddbtpquX LSX - partnering for Life Science eXecutives #messengersinscience

🔥🔥 Last Day to Register! As we have reached full capacity earlier for the 2023 #H7 Healthcare Investment Forum & Demo Day on December 7th, registration will officially close at 11:59 pm PST on December 4th. If you haven't registered yet, this is your last opportunity to secure your spot at the event! 👏👏 We are thrilled to announce the Complete Speaker Lineup! - Bill Reichert, General Partner, Pegasus Tech Ventures - Ronjon Nag, Managing Director & CEO, R42 Group - Jian(Jay) Lin, Senior Director External Innovation DPDS, Johnson & Johnson - Mike Ryan, Managing Partner, MGR Capital - Gary Goldman MD, DDS, MBA, Founding Partner, Global Health Impact Fund - Neil Littman, Founder & Managing Director, Bioverge Ventures - Nola E. Masterson E Masterson, Lead Investor, Portfolios Femtech Fund - Paul Grewal, Partner, SIC Venture Studio - Brian💥 Sparkes, Head of Communication, Bay Angels - Aditya Asokan, Investor, Samsara BioCapital - Robert E. "Bob" Sweeney, Cofounder, Global Health Impact Network - Harneet Bath, MD, VP, VEP Healthcare/USACS West Region -Xiaoxiao Liu, Partner, IncepVision Law P.C. -Sherri Douville, CEO, Medigram ❤️ A heartfelt thank you to our sponsors:  - Morrison Foerster - PeopleConnect - IncepVision Law P.C. - Prop Consulting Corporation 🍁 We have also confirmed these exciting pitching companies: • Cellicure, Inc., providing innovative cell-based immunotherapy technologies with a rich pipeline of products. • QuanMol Technology, an automated platform for drug optimization. • Microvascular Therapeutics, a clinical stage biopharma pioneering in ultrasound contrast agents and theranostics. • Novall, pioneering novel nitric oxide delivery devices targeting unmet needs in cardiopulmonary and antimicrobial medicine. 🎯Registration: https://shorturl.at/rvS58 Q. Frank Li, MD, PhD, Xingyu Shen, Emmanuelle J. Meuillet, Niki Gastinel #healthcare #lifesciences #medtech #ai #fundraising #vc #tech #pitching #biotech #accelerator #venture #unicorn #exit #startup #entrepreneurship

#Nomatterwhat challenges arise, Israel consistently shows its innovative spirit! We remain open for business and are dedicated to every one of our clients. It's inspiring to see our companies drive even in challenging times. This resilience is a testament to their strength, further solidifying Israel's position as a leader in the tech industry, especially in health tech. Joya Marketing is proud to support our companies and startups. Additionally, the Israel Innovation Authority is diligently offering extended support to Israeli companies. Discover more about our companies: Eitan Medical, CalleoHealth, Ltd., MindUP - The Digital Health Incubator, Plas-Free, NGT , IntraGel Therapeutics, SURE Universal Ltd., JaxBio, Sealantium Medical, IceCure Medical, Ark Surgical Ltd., Pluri, Pepticom Ltd., Cliniture, CaleeTech, Baccine, Curesponse, Euroresearch Srl #StartupNation #InvestInIsrael #IsraeliTech #Innovation

🔥🔥 Last Day to Register! As we have reached full capacity earlier for the 2023 #H7 Healthcare Investment Forum & Demo Day on December 7th, registration will officially close at 11:59 pm PST on December 4th. If you haven't registered yet, this is your last opportunity to secure your spot at the event! 👏👏 We are thrilled to announce the Complete Speaker Lineup! - Bill Reichert, General Partner, Pegasus Tech Ventures - Ronjon Nag, Managing Director & CEO, R42 Group - Jian(Jay) Lin, Senior Director External Innovation DPDS, Johnson & Johnson - Mike Ryan, Managing Partner, MGR Capital - Gary Goldman MD, DDS, MBA, Founding Partner, Global Health Impact Fund - Neil Littman, Founder & Managing Director, Bioverge Ventures - Nola E. Masterson E Masterson, Lead Investor, Portfolios Femtech Fund - Paul Grewal, Partner, SIC Venture Studio - Brian💥 Sparkes, Head of Communication, Bay Angels - Aditya Asokan, Investor, Samsara BioCapital - Robert E. "Bob" Sweeney, Cofounder, Global Health Impact Network - Harneet Bath, MD, VP, VEP Healthcare/USACS West Region -Xiaoxiao Liu, Partner, IncepVision Law P.C. -Sherri Douville, CEO, Medigram ❤️ A heartfelt thank you to our sponsors:  - Morrison Foerster - PeopleConnect - IncepVision Law P.C. - Prop Consulting Corporation 🍁 We have also confirmed these exciting pitching companies: • Cellicure, Inc., providing innovative cell-based immunotherapy technologies with a rich pipeline of products. • QuanMol Technology, an automated platform for drug optimization. • Microvascular Therapeutics, a clinical stage biopharma pioneering in ultrasound contrast agents and theranostics. • Novall, pioneering novel nitric oxide delivery devices targeting unmet needs in cardiopulmonary and antimicrobial medicine. 🎯Registration: https://shorturl.at/rvS58 Q. Frank Li, MD, PhD, Xingyu Shen, Emmanuelle J. Meuillet, Niki Gastinel #healthcare #lifesciences #medtech #ai #fundraising #vc #tech #pitching #biotech #accelerator #venture #unicorn #exit #startup #entrepreneurship

🇫🇷 (1/2) France is Investing in Biotech Innovation: Last week, I attended Viva Technology 2024 and discovered that France represented more biotech-based startups than any other country. Let’s dive into the CNRS - Centre national de la recherche scientifique (CNRS) stand, one of the biggest scientific institutions in French research: Biomemory TECH: DNA-based data storage. Their innovative approach leverages the long-term stability and high density of DNA to store vast amounts of data. The process is sustainable, significantly reducing carbon emissions compared to traditional data storage methods such as magnetic tapes. BUSINESS: In 2022, they raised €5M in a seed round, attracting several big investors. Their aim is to commercialize their DNA data storage solutions by focusing on reducing costs and improving technology scalability. By optimizing their product, they expect to have a cost-competitive solution with traditional storage methods within the next few years. Vect-Horus TECH: Peptide-based vectors for drug delivery across the blood-brain barrier (BBB). Their technology enables more effective delivery of therapeutic agents to targeted tissues, enhancing the efficacy and safety of treatments. BUSINESS: The company's plan focuses on advancing their drug delivery technology through preclinical and clinical stages. They have already licensed one of their technologies to Novo Nordisk but still have candidates to pursue with in-house development. France seems to be committed to biotech innovation, and I am excited to see how these startups will shape the future of healthcare and technology. Let's continue to deepen on the event and the other proposals from the CNRS tomorrow. #Biotech #Innovation #France #VivaTech2024 #CNRS #DNADataStorage #Startups #TechTrends #ScienceAndTechnology #ResearchAndDevelopment #BiotechStartups